Gypsyamber D'Souza
Alma materSwarthmore College (BA)
University of Wisconsin–Madison (MS)
University of Texas Health Science Center at Houston (MPH)
Johns Hopkins Bloomberg School of Public Health (PhD)
Scientific career
FieldsInfectious diseases, behavioral risk management, translational epidemiology
InstitutionsJohns Hopkins Bloomberg School of Public Health
ThesisOropharyngeal cancer attributable to human papillomavirus 16 (HPV16) infection (2006)
Doctoral advisorPatti Gravitt
Maura L. Gillison

Gypsyamber D'Souza is an American epidemiologist. She is a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. D'Souza researches infectious diseases (including HPV, HIV, and SARS-CoV-2), cancer prevention, and translational epidemiology. She is a principal investigator of the Multicenter AIDS Cohort Study / Women's Interagency HIV Study Combined Cohort Study (Mwccs.org).

Education

D'Souza earned a B.A. from Swarthmore College in 1996 and a M.S. from University of Wisconsin–Madison in 1999. She completed a M.P.H. at University of Texas Health Science Center at Houston in 2001 and a Ph.D. at Johns Hopkins Bloomberg School of Public Health in 2007.[1] Her dissertation was titled Oropharyngeal cancer attributable to human papillomavirus 16 (HPV16) infection. Her doctoral advisors were Patti Gravitt and Maura L. Gillison.[2]

Career and research

D'Souza is a professor in the division of cancer epidemiology within the department of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is jointly affiliated in the division of global disease epidemiology and control within the department of international health and the Johns Hopkins School of Medicine.[1]

D'Souza researches infectious diseases, behavioral risk management, and translational epidemiology. She is the lead of a HPV and related cancer research program that also investigates risk triage and risk communication.[1] D'Souza is a principal investigator on the Multicenter AIDS Cohort Study (MACS) / Women's Interagency HIV Study (WIHS) Combined Cohort Study (MACS/WIHS-CSS), a collaborative research effort that aims to understand and reduce the impact of chronic health conditions—including heart, lung, blood, and sleep (HLBS) disorders—that affect people living with HIV.[1][3]

References

  1. 1 2 3 4 "Gypsyamber D'Souza - Faculty Directory". Johns Hopkins Bloomberg School of Public Health. Retrieved April 15, 2020.
  2. ↑ D'Souza, Gypsyamber (2006). Oropharyngeal cancer attributable to human papillomavirus 16 (HPV16) infection (Thesis). OCLC 145733188.
  3. ↑ "NHLBI HIV/AIDS Program | National Heart, Lung, and Blood Institute (NHLBI)". www.nhlbi.nih.gov. Retrieved April 15, 2020.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.